Abstract Rheumatoid arthritis (RA) is a chronic inflammatory disease with fluctuating course of progression. Despite substantial improvement in treatments in recent years, treatment response is still not guaranteed. The aim of this study was to identify variation in Disease Activity Score 28 (DAS28) of RA patients in response to Tocilizumab, and to investigate both molecular […]
Identification of heterogenous treatment response trajectories to anti-IL6 receptor treatment in rheumatoid arthritis.
August 18, 2020
Sci Rep